1,448
Views
0
CrossRef citations to date
0
Altmetric
Microbiology

Development of a minimal invasive and controllable murine model to study polymicrobial abdominal sepsis

, , , , , , , & show all
Pages 265-276 | Received 10 Feb 2021, Accepted 23 Mar 2021, Published online: 08 Apr 2021

References

  • Al Asmari AK, Al Sadoon KT, Obaid AA, Yesunayagam D, Tariq M. 2017. Protective effect of quinacrine against glycerol-induced acute kidney injury in rats. BMC Nephrol. 18(1):41.
  • Buras JA, Holzmann B, Sitkovsky M. 2005. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 4(10):854–865.
  • Cross AS, Opal SM, Sadoff JC, Gemski P. 1993. Choice of bacteria in animal models of sepsis. Infect Immun. 61(7):2741–2747.
  • Dan M, Richardson J, Miliotis MD, Koornhof HJ. 1989. Comparison of preservation media and freezing conditions for storage of specimens of faeces. J Med Microbiol. 28(2):151–154.
  • Das P, Panda SK, Agarwal B, Behera S, Ali SM, Pulse ME, Solomkin JS, Opal SM, Bhandari V, Acharya S. 2019. Novel Chitohexaose analog protects young and aged mice from CLP induced polymicrobial sepsis. Sci Rep. 9(1):2904.
  • Dejager L, Pinheiro I, Dejonckheere E, Libert C. 2011. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol. 19(4):198–208.
  • Dyson A, Singer M. 2009. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med. 37(1 Suppl):S30–S37.
  • Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D. 1999. Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun. 67(12):6603–6610.
  • Fink MP. 2014. Animal models of sepsis. Virulence. 5(1):143–153.
  • Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge L, Kenney JS, Remick DG, Bloedow DC. 1992. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 89(5):1551–1557.
  • Fleischmann C, Thomas-Rueddel DO, Hartmann M, Hartog CS, Welte T, Heublein S, Dennler U, Reinhart K. 2016. Hospital incidence and mortality rates of sepsis. Dtsch Arzteblatt Int. 113(10):159–166.
  • Gonnert FA, Recknagel P, Seidel M, Jbeily N, Dahlke K, Bockmeyer CL, Winning J, Lösche W, Claus RA, Bauer M. 2011. Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J Surg Res. 170(1):e123–e134.
  • Hawkins P. 2002. Recognizing and assessing pain, suffering and distress in laboratory animals: a survey of current practice in the UK with recommendations. Lab Anim. 36(4):378–395.
  • Hilbert T, Steinhagen F, Senzig S, Cramer N, Bekeredjian-Ding I, Parcina M, Baumgarten G, Hoeft A, Frede S, Boehm O, Klaschik S. 2017. Vendor effects on murine gut microbiota influence experimental abdominal sepsis. J Surg Res. 211:126–136.
  • Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, Bland KI, Chaudry IH. 2005. Cecal ligation and puncture. Shock Augusta Ga. 24(Suppl 1):52–57.
  • Kim JH, Lee D-W, Jung MH, Cho H-S, Jeon D-H, Chang S-H, Park DJ. 2014. Macrophage depletion ameliorates glycerol-induced acute kidney injury in mice. Nephron Exp Nephrol. 128(1–2):21–29.
  • Kingsley SMK, Bhat BV. 2016. Differential paradigms in animal models of sepsis. Curr Infect Dis Rep. 18(9):26.
  • Krakauer T, Buckley MJ, Fisher D. 2010. Proinflammatory mediators of toxic shock and their correlation to lethality. Mediators Inflamm. 2010:517594:1-7.
  • Lang CH, Bagby GJ, Bornside GH, Vial LJ, Spitzer JJ. 1983. Sustained hypermetabolic sepsis in rats: characterization of the model. J Surg Res. 35(3):201–210.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods San Diego Calif. 25(4):402–408.
  • Maslove DM, Wong HR. 2014. Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med. 20(4):204–213.
  • Morton DB, Griffiths PH. 1985. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec. 116(16):431–436.
  • Nara A, Yajima D, Nagasawa S, Abe H, Hoshioka Y, Iwase H. 2016. Evaluations of lipid peroxidation and inflammation in short-term glycerol-induced acute kidney injury in rats. Clin Exp Pharmacol Physiol. 43(11):1080–1086.
  • Osuchowski MF, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon J-M, Chaudry IH, Coopersmith CM, Deutschman CS, Drechsler S, et al. 2018. Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International expert Consensus initiative for improvement of animal modeling in sepsis. Shock Augusta Ga. 50(4):377–380.
  • Panda SK, Kumar S, Tupperwar NC, Vaidya T, George A, Rath S, Bal V, Ravindran B. 2012. Chitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemia. PLoS Pathog. 8(5):e1002717:1-17.
  • Parker SJ, Watkins PE. 2001. Experimental models of gram-negative sepsis. Br J Surg. 88(1):22–30.
  • Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 4(1):31–36.
  • Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. 2020. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global burden of disease study. Lancet Lond Engl. 395(10219):200–211.
  • Sam AD, Sharma AC, Law WR, Ferguson JL. 1997. Splanchnic vascular control during sepsis and endotoxemia. Front Biosci J Virtual Libr. 2:e72–e92.
  • Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al. 2016. Assessment of clinical Criteria for sepsis: For the third International Consensus Definitions for Sepsis and Septic Shock (sepsis-3). JAMA. 315(8):762–774.
  • Shrum B, Anantha RV, Xu SX, Donnelly M, Haeryfar SMM, McCormick JK, Mele T. 2014. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes. 7:233.
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, et al. 2016. The third International Consensus Definitions for Sepsis and Septic Shock (sepsis-3). JAMA. 315(8):801–810.
  • Skirecki T, Drechsler S, Hoser G, Jafarmadar M, Siennicka K, Pojda Z, Kawiak J, Osuchowski MF. 2019. The fluctuations of leukocytes and circulating cytokines in septic humanized mice vary With outcome. Front Immunol. 10:1427.
  • Starr ME, Steele AM, Saito M, Hacker BJ, Evers BM, Saito H. 2014. A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis. PloS One. 9(12):e115705:1-15.
  • Stortz JA, Raymond SL, Mira JC, Moldawer LL, Mohr AM, Efron PA. 2017. Murine models of sepsis and trauma: Can We bridge the Gap? ILAR J. 58(1):90–105.
  • Taylor FB. 2001. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Crit Care Med. 29(7 Suppl):S78–S89.
  • Weinstein WM, Onderdonk AB, Bartlett JG, Gorbach SL. 1974. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun. 10(6):1250–1255.
  • Wichterman KA, Baue AE, Chaudry IH. 1980. Sepsis and septic shock–a review of laboratory models and a proposal. J Surg Res. 29(2):189–201.
  • Wynn JL, Scumpia PO, Delano MJ, O’Malley KA, Ungaro R, Abouhamze A, Moldawer LL. 2007. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock Augusta Ga. 28(6):675–683.
  • Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, Heidecke CD, Pfeffer K. 1998. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun. 66(5):2300–2309.